Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 7 studies | 34% ± 18% | |
goblet cell | 6 studies | 39% ± 12% | |
intestinal crypt stem cell | 4 studies | 59% ± 8% | |
transit amplifying cell | 4 studies | 47% ± 24% | |
paneth cell | 3 studies | 94% ± 5% | |
epithelial cell | 3 studies | 39% ± 15% | |
acinar cell | 3 studies | 99% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1840153.39 | 328 / 328 | 71% | 3325.87 | 127 / 178 |
stomach | 89% | 17987.33 | 319 / 359 | 52% | 1225.81 | 148 / 286 |
kidney | 91% | 2705.15 | 81 / 89 | 32% | 87.46 | 292 / 901 |
intestine | 61% | 35197.02 | 594 / 966 | 56% | 1079.44 | 297 / 527 |
liver | 67% | 241.00 | 152 / 226 | 13% | 165.00 | 54 / 406 |
esophagus | 48% | 258.98 | 692 / 1445 | 29% | 737.37 | 53 / 183 |
spleen | 73% | 244.18 | 175 / 241 | 0% | 0 | 0 / 0 |
bladder | 57% | 92.52 | 12 / 21 | 14% | 306.11 | 69 / 504 |
ovary | 62% | 189.23 | 112 / 180 | 4% | 10.62 | 19 / 430 |
adrenal gland | 65% | 167.61 | 167 / 258 | 0% | 0.61 | 1 / 230 |
uterus | 58% | 172.56 | 98 / 170 | 2% | 54.55 | 10 / 459 |
prostate | 51% | 175.50 | 125 / 245 | 0% | 0.10 | 1 / 502 |
lung | 40% | 140.12 | 231 / 578 | 10% | 178.77 | 118 / 1155 |
thymus | 41% | 131.32 | 269 / 653 | 0% | 0.31 | 1 / 605 |
breast | 40% | 311.00 | 184 / 459 | 0% | 0.67 | 3 / 1118 |
blood vessel | 38% | 423.72 | 511 / 1335 | 0% | 0 | 0 / 0 |
adipose | 36% | 635.32 | 437 / 1204 | 0% | 0 | 0 / 0 |
skin | 34% | 101.33 | 620 / 1809 | 0% | 3.98 | 2 / 472 |
peripheral blood | 32% | 79.86 | 297 / 929 | 0% | 0 | 0 / 0 |
heart | 32% | 147.01 | 273 / 861 | 0% | 0 | 0 / 0 |
brain | 28% | 105.95 | 732 / 2642 | 0% | 0 | 0 / 705 |
muscle | 25% | 67.31 | 201 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0043434 | Biological process | response to peptide hormone |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0070492 | Molecular function | oligosaccharide binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
Gene name | REG1A |
Protein name | REG1A protein Lithostathine-1-alpha (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP) (Regenerating islet-derived protein 1-alpha) (REG-1-alpha) (Regenerating protein I alpha) |
Synonyms | REG PSPS1 PSPS |
Description | FUNCTION: Might act as an inhibitor of spontaneous calcium carbonate precipitation. May be associated with neuronal sprouting in brain, and with brain and pancreas regeneration. |
Accessions | Q2TBE1 P05451 ENST00000233735.2 |